KR930000114A - 지방산을 이용한 치료 - Google Patents
지방산을 이용한 치료 Download PDFInfo
- Publication number
- KR930000114A KR930000114A KR1019920009760A KR920009760A KR930000114A KR 930000114 A KR930000114 A KR 930000114A KR 1019920009760 A KR1019920009760 A KR 1019920009760A KR 920009760 A KR920009760 A KR 920009760A KR 930000114 A KR930000114 A KR 930000114A
- Authority
- KR
- South Korea
- Prior art keywords
- day
- essential fatty
- medicament
- fatty acid
- urinary excretion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title claims 2
- 229930195729 fatty acid Natural products 0.000 title claims 2
- 239000000194 fatty acid Substances 0.000 title claims 2
- 150000004665 fatty acids Chemical class 0.000 title claims 2
- 238000000034 method Methods 0.000 claims 9
- 235000004626 essential fatty acids Nutrition 0.000 claims 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 6
- 229910052791 calcium Inorganic materials 0.000 claims 6
- 239000011575 calcium Substances 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 230000036325 urinary excretion Effects 0.000 claims 6
- 206010029148 Nephrolithiasis Diseases 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 3
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 claims 2
- 208000000913 Kidney Calculi Diseases 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 159000000007 calcium salts Chemical class 0.000 claims 2
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9112052.7 | 1991-06-05 | ||
| GB919112052A GB9112052D0 (en) | 1991-06-05 | 1991-06-05 | Fatty acid treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR930000114A true KR930000114A (ko) | 1993-01-15 |
Family
ID=10696108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019920009760A Ceased KR930000114A (ko) | 1991-06-05 | 1992-06-05 | 지방산을 이용한 치료 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5318991A (https=) |
| EP (1) | EP0517425A1 (https=) |
| JP (1) | JPH05178744A (https=) |
| KR (1) | KR930000114A (https=) |
| AU (1) | AU659456B2 (https=) |
| CA (1) | CA2070468A1 (https=) |
| FI (1) | FI922582L (https=) |
| GB (1) | GB9112052D0 (https=) |
| IE (1) | IE921806A1 (https=) |
| NO (1) | NO302100B1 (https=) |
| NZ (1) | NZ242897A (https=) |
| SG (1) | SG49682A1 (https=) |
| TW (1) | TW200397B (https=) |
| ZA (1) | ZA923915B (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5516801A (en) * | 1992-08-21 | 1996-05-14 | Scotia Holdings Plc | Fatty acid treatment for ectopic calcium deposition |
| GB9217780D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
| GB9217781D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
| US5888541A (en) * | 1992-08-21 | 1999-03-30 | Scotia Holdings Plc | Fatty acid treatment |
| AU683027B2 (en) * | 1993-01-27 | 1997-10-30 | Scotia Holdings Plc | Triglycerides |
| FR2704390B1 (fr) * | 1993-04-29 | 1995-06-02 | Boiron | Complément nutritionnel absorbable per-os destiné à améliorer la peau. |
| DE69326949T2 (de) * | 1993-08-20 | 2000-02-17 | Societe Des Produits Nestle S.A., Vevey | Lipidzusammensetzung für Nahrungsmittel |
| US5668174A (en) * | 1993-12-29 | 1997-09-16 | Kowa Tekuno Sachi Co., Ltd. | Method of treating hyperparathyroidism |
| EP0711503A3 (en) * | 1994-11-14 | 1997-11-26 | Scotia Holdings Plc | Milk fortified with GLA and/or DGLA |
| US5804210A (en) * | 1996-08-07 | 1998-09-08 | Wisconsin Alumni Research Foundation | Methods of treating animals to maintain or enhance bone mineral content and compositions for use therein |
| WO1999003456A2 (en) * | 1997-07-16 | 1999-01-28 | Societe Des Produits Nestle S.A. | Method for prophylaxis or treatment of bone density loss |
| US6479545B1 (en) * | 1999-09-30 | 2002-11-12 | Drugtech Corporation | Formulation for menopausal women |
| ES2289097T3 (es) * | 2001-03-15 | 2008-02-01 | Dsm Ip Assets B.V. | Composicion para la prevencion de la osteoporosis consistente de una combinacion de isoflavonas y acidos grasos poliinsaturados. |
| US6576667B2 (en) * | 2001-11-14 | 2003-06-10 | Norel Acquisition Corp. | Method for manufacturing fatty acid calcium salts from high glyceride content oils |
| US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
| US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
| US8728546B1 (en) | 2013-03-15 | 2014-05-20 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer, cardiovascular diseases and inflammation |
| US9682055B2 (en) | 2014-06-04 | 2017-06-20 | Dignity Sciences Limted | Pharmaceutical compositions comprising DGLA and use of same |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1417119A (en) * | 1972-11-30 | 1975-12-10 | Thiele G H | Process for treating bones |
| EP0150248B1 (de) * | 1984-02-01 | 1988-10-19 | T P O "Pharmachim" | Mittel zur Behandlung und Prophylaxe uratischer und gemischter uratischer Lithiasis |
| GB8621816D0 (en) * | 1986-09-10 | 1986-10-15 | Efamol Ltd | Therapeutic composition |
| JPH0625057B2 (ja) * | 1987-12-14 | 1994-04-06 | 日本油脂株式会社 | 骨形成促進剤 |
| US4855736A (en) * | 1988-06-03 | 1989-08-08 | Hsu Chi Heng | Electronic parking sensor apparatus |
| GB8813766D0 (en) * | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
| GB9001121D0 (en) * | 1990-01-18 | 1990-03-21 | Efamol Holdings | Efa compositions and therapy |
| GB9002048D0 (en) * | 1990-01-30 | 1990-03-28 | Efamol Holdings | Essential fatty acid compositions and treatments |
-
1991
- 1991-06-05 GB GB919112052A patent/GB9112052D0/en active Pending
-
1992
- 1992-05-26 NZ NZ242897A patent/NZ242897A/en unknown
- 1992-05-27 ZA ZA923915A patent/ZA923915B/xx unknown
- 1992-05-28 EP EP92304819A patent/EP0517425A1/en not_active Withdrawn
- 1992-05-28 SG SG1996004058A patent/SG49682A1/en unknown
- 1992-05-29 AU AU17266/92A patent/AU659456B2/en not_active Ceased
- 1992-06-04 FI FI922582A patent/FI922582L/fi not_active Application Discontinuation
- 1992-06-04 CA CA002070468A patent/CA2070468A1/en not_active Abandoned
- 1992-06-04 NO NO922214A patent/NO302100B1/no not_active IP Right Cessation
- 1992-06-05 KR KR1019920009760A patent/KR930000114A/ko not_active Ceased
- 1992-06-05 JP JP4145421A patent/JPH05178744A/ja active Pending
- 1992-06-16 TW TW081104701A patent/TW200397B/zh active
- 1992-07-01 IE IE180692A patent/IE921806A1/en not_active Application Discontinuation
-
1993
- 1993-04-22 US US08/051,436 patent/US5318991A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| TW200397B (https=) | 1993-02-21 |
| AU1726692A (en) | 1992-12-10 |
| FI922582A0 (fi) | 1992-06-04 |
| US5318991A (en) | 1994-06-07 |
| NZ242897A (en) | 1997-06-24 |
| IE921806A1 (en) | 1992-12-16 |
| GB9112052D0 (en) | 1991-07-24 |
| CA2070468A1 (en) | 1992-12-06 |
| NO302100B1 (no) | 1998-01-26 |
| SG49682A1 (en) | 1998-06-15 |
| ZA923915B (en) | 1993-02-24 |
| EP0517425A1 (en) | 1992-12-09 |
| NO922214D0 (no) | 1992-06-04 |
| FI922582A7 (fi) | 1992-12-06 |
| AU659456B2 (en) | 1995-05-18 |
| JPH05178744A (ja) | 1993-07-20 |
| FI922582L (fi) | 1992-12-06 |
| NO922214L (no) | 1992-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR930000114A (ko) | 지방산을 이용한 치료 | |
| KR940003553A (ko) | 지방산을 함유하는 조성물 및 지방산을 이용한 처지방법 | |
| KR940018089A (ko) | 내부조직의 방사선 손상에 대한 예방 및 처치방법 | |
| KR920002144A (ko) | 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제 | |
| IT1255390B (it) | Prodotti farmaceutici per curare malattie tumorali e procedimento per la loro preparazione | |
| RU93049153A (ru) | Лечение жирными кислотами | |
| KR910019640A (ko) | 클로스트리듐 디피실레 하리증 및 위막성 대장염의 예방 및 치료용 의약조성물 | |
| KR920000324A (ko) | 필수 지방산 처리법 | |
| KR960000219A (ko) | 당뇨병 합병증 치료용 조성물 | |
| KR930007441A (ko) | 의약품 | |
| RU2000132310A (ru) | Применение продуктов на основе магния для лечения или профилактики опухолевых и аутоиммунных заболеваний | |
| BR9916114A (pt) | Uso de apomorfina na fabricação de um medicamento para tratamento de disfunção erétil orgânica masculina | |
| RU2002121546A (ru) | Вещества, предназначенные для лечения псориаза | |
| KR910005858A (ko) | 지방산 요법 | |
| DE68926115D1 (de) | Verfahren zur behandlung von akne | |
| US5516801A (en) | Fatty acid treatment for ectopic calcium deposition | |
| Cathcart III | The method of determining proper doses of vitamin C for the treatment of disease by titrating to bowel tolerance | |
| KR940003552A (ko) | 지방산을 이용한 석회화 예방 및 치료방법 | |
| KR890003390A (ko) | 골다공증 및 관련된 장해의 치료방법 | |
| KR850004393A (ko) | 경구 투여용 지효성(遲效性) 아세틸살리실산 제제 | |
| KR920702225A (ko) | 약학 조성물 | |
| KR900005974A (ko) | 남성의 성기능 장애 치료제 | |
| JPS57126420A (en) | Drug for digestive organ | |
| KR910009267A (ko) | 우울증의 치료방법 | |
| KR930003913A (ko) | 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19920605 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19970605 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19920605 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19990223 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19990428 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19990223 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |